Citations

Showing 10 of 108048 citations.

Acceleration of Brain Injury Biomarker Abnormalities in Cognitively Normal Elderly with β-Amyloidosis (IN3-1.001)
Wiste, Heather J. , Weigand, Stephen D. , Lowe, Val J. , Gunter, Jeffery, Roberts, Rosebud O., Petersen, Ronald C. , Knopman, David S. , Jack, Clifford R. , Vemuri, Prashanthi , Kantarci, Kejal , Senjem, Matthew L. , Mielke, Michelle M. , Boeve, Bradley F.

Mayo Clinic

Neurology | December 7, 2023 | Volume: 80 | Issue: 7_supplement | Pages: No page available

10.1212/wnl.80.7_supplement.in3-1.001 Get It

Autosomal-Dominant Parkinsonism Associated with a Newly Described Mutation in DNAJC13: Clinical, Imaging and Pathological Description (IN2-2.002)
Rajput, Ali H. , Rajput, Michele L., Thompson, Christina, Shah, Brinda, Weir, David , McKenzie, Jessamyn , McCormick, Siobhan, Rajput, Alexander, Appel‐Cresswell, Silke , Vilariño‐Güell, Carles , Stoessl, A. Jon , Sossi, Vesna , Dickson, Dennis W. , Farrer, Matthew J.

Mayo Clinic

Neurology | December 7, 2023 | Volume: 80 | Issue: 7_supplement | Pages: No page available

10.1212/wnl.80.7_supplement.in2-2.002 Get It

Comparison of DRD2, DRD3 and NMDA Receptor Genotype Polymorphisms in Parkinson's Patients and Controls (IN2-1.007)
Serie, Daniel, Ahlskog, J. Eric , Hassan, Anhar , Okun, Michael S. , Heckman, Michael G. , Ross, Owen A.

Mayo Clinic

Neurology | December 7, 2023 | Volume: 80 | Issue: 7_supplement | Pages: No page available

10.1212/wnl.80.7_supplement.in2-1.007 Get It

Genetic Evidence for a Dual and Opposing Effect of alpha-Synuclein Expression in Preclinical Versus Clinical Parkinson's Disease (IN2-1.003)
Markopoulou, Katerina , Ahlskog, J. Eric , Anderson, Kari, Armasu, Sebastian M. , Cunningham, Julie L. , Frigerio, Roberta , Maraganore, Demetrius M. , Biernacka, Joanna M. , Chung, Sun Ju

Mayo Clinic

Neurology | December 7, 2023 | Volume: 80 | Issue: 7_supplement | Pages: No page available

10.1212/wnl.80.7_supplement.in2-1.003 Get It

Salivary Gland Biopsy as a Diagnostic Test for Parkinson's Disease (IN2-1.002)
Adler, Charles, Beach, Thomas G. , Hinni, Michael L., Driver‐Dunckley, Erika , Nagel, Thomas H. , Dugger, Brittany N. , Lott, David G.

Mayo Clinic

Neurology | December 7, 2023 | Volume: 80 | Issue: 7_supplement | Pages: No page available

10.1212/wnl.80.7_supplement.in2-1.002 Get It

Hirayama Disease in Children from North America (IN1-1.009)
Ghosh, Partha S. , Moodley, Manikum , Rothner, A. David, Ghosh, Debabrata , Friedman, Neil

Mayo Clinic

Neurology | December 7, 2023 | Volume: 80 | Issue: 7_supplement | Pages: No page available

10.1212/wnl.80.7_supplement.in1-1.009 Get It

The Stiff Child (IN1-1.004)
Clardy, Stacey , Jones, H. Royden, Renaud, Deborah L. , Harper, C. Michel , Matsumoto, Joseph Y., Lennon, Vanda A. , Clardy, Stacey L , Pittock, Sean J. , Dalmau, Josep , McKeon, Andrew

Mayo Clinic

Neurology | December 7, 2023 | Volume: 80 | Issue: 7_supplement | Pages: No page available

10.1212/wnl.80.7_supplement.in1-1.004 Get It

A Spontaneously Resolving Pyridostigmine Responsive Congenital Myasthenic Syndrome Caused by Isolated PREPL Deficiency (IN1-1.001)
Selcen, Duygu , Shen, Xin , Meulemans, Sandra, Creemers, John W.M. , Engel, Andrew, Régal, Luc

Mayo Clinic

Neurology | December 7, 2023 | Volume: 80 | Issue: 7_supplement | Pages: No page available

10.1212/wnl.80.7_supplement.in1-1.001 Get It

Heart of the matter—infection and xenotransplantation
Saharia, Kapil , Hall, Victoria , Chesdachai, Supavit , Porrett, Paige M. , Fishman, Jay A. , Pouch, Stephanie M. , Saharia, Kapil K , Hall, Victoria G , Chesdachai, Supavit , Porrett, Paige , Fishman, Jay A , Pouch, Stephanie M

Mayo Clinic

Transplant Infectious Disease | December 7, 2023 | Volume: 26 | Issue: 1 | Pages: No page available

10.1111/tid.14206 | PMID 38055610 Get It

AbstractIn this clinicopathological conference, invited experts discussed a previously published case of a patient with nonischemic cardiomyopathy who underwent heart transplantation from a genetically modified pig source animal. His complex course included detection of porcine cytomegalovirus by plasma microbial cell‐free DNA and eventual xenograft failure. The objectives of the session included discussion of selection of immunosuppressive regimens and prophylactic antimicrobials for human xenograft recipients, description of infectious disease risk assessment and mitigation in potential xenograft donors and understanding of screening and therapeutic strategies for potential xenograft‐related infections. image
Maternal Factors and Placental Pathologies Associated with a Diagnosis of Chronic Villitis
Rose, Sherrill, Nguyen, Eliza M., Melo, Valéria , Vega, Beatriz , Kazemi-Butterfield, Nazanin, Cheek‐Norgan, E. Heidi, Theiler, Regan N. , Enninga, Elizabeth Ann L. , Rose, Sherrill J, Branda, Megan E. , Cheek-Norgan, E Heidi, Enninga, Elizabeth Ann L , Theiler, Regan , Vega, Beatriz, Girard, Sylvie , Norgan, Andrew P.

Mayo Clinic

American Journal of Perinatology | December 7, 2023 | Volume: 41 | Issue: S 01 | Pages: e3351-e3362

10.1055/a-2223-3348 | PMID 38057089 Get It

Objective To evaluate maternal risk factors associated with chronic villitis of unknown etiology (VUE) and to describe cooccurring placental pathologies. Study Design A retrospective case–control study was conducted using placental pathology records from deliveries ≥ 20 weeks between 2010 and 2018. Cases were placentas with documented chronic villitis without infectious cause, hereafter called VUE. Controls were placentas without this diagnosis, matched to the cases 2:1. Maternal and neonatal demographic and clinical data were collected. Descriptive statistics are reported with Fisher's exact test or a chi-squared test, as appropriate, and multivariable conditional logistic regression was conducted. Results Our study included 352 cases with VUE and 657 controls. A diagnosis of gestational diabetes (p = 0.03) and gestational hypertension (p = 0.06) was 1.5 times more likely to occur in those with a VUE diagnosis. A trend was also seen for chronic hypertension (odds ratio [OR] = 1.7, p = 0.07) and preeclampsia (OR = 1.5, p = 0.09) compared with controls. Placentas with VUE, specifically high-grade VUE, were more likely to be small for gestational age (p = 0.01), and to be diagnosed with other placental findings including lymphoplasmacytic or chronic deciduitis (p < 0.01), maternal (p < 0.01) and fetal vascular malperfusion (p = 0.02), and chorionitis (acute or chronic; p < 0.01). Conclusion Gestational diabetes and hypertension were associated with a diagnosis of VUE, and overall, VUE placentas have more abnormal placental findings compared with control. Understanding VUE risk factors may facilitate prenatal care strategies and counseling to achieve the best outcomes for pregnant patients and their neonates. Key Points